Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?

Anti-EGFR therapy and antiangiogenic therapies are used alone or in combination with chemotherapies to improve survival in metastatic colorectal cancer. However, it is unknown whether pretreatment with antiangiogenic therapy could impact on the efficacy of anti-EGFR therapy. We selected one hundred...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncotarget
Main Authors: Derangère, Valentin, Fumet, Jean David, Boidot, Romain, Bengrine, Leila, Limagne, Emeric, Chevriaux, Angélique, Vincent, Julie, Ladoire, Sylvain, Apetoh, Lionel, Rébé, Cédric, Ghiringhelli, François
格式: Artigo
語言:Inglês
出版: Impact Journals LLC 2016
主題:
Research Paper
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4891042/
https://ncbi.nlm.nih.gov/pubmed/26824184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7008
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍